Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical efficacy of simultaneous splenectomy in liver transplant recipients with hepatitis C virus.
Morimoto H, Ishiyama K, Ishifuro M, Ohira M, Ide K, Tanaka Y, Tahara H, Teraoka Y, Yamashita M, Abe T, Hashimoto S, Hirata F, Tanimine N, Saeki Y, Shimizu S, Sakai H, Yano T, Tashiro H, Ohdan H. Morimoto H, et al. Among authors: hashimoto s. Transplant Proc. 2014 Apr;46(3):770-3. doi: 10.1016/j.transproceed.2013.12.034. Transplant Proc. 2014. PMID: 24767345
Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis.
Sakai H, Ishiyama K, Tanaka Y, Ide K, Ohira M, Tahara H, Abe T, Hirata F, Morimoto H, Hashimoto S, Tanimine N, Saeki Y, Shimizu S, Yano T, Kobayashi T, Tashiro H, Ohdan H. Sakai H, et al. Among authors: hashimoto s. Transplant Proc. 2014 Apr;46(3):785-9. doi: 10.1016/j.transproceed.2013.11.123. Transplant Proc. 2014. PMID: 24767349
Bile CXC motif chemokine 10 levels correlate with anti-donor cytotoxic T cell responses after liver transplantation.
Morimoto H, Ide K, Tanaka Y, Ishiyama K, Ohira M, Tahara H, Teraoka Y, Yamashita M, Abe T, Hashimoto S, Hirata F, Tanimine N, Saeki Y, Shimizu S, Sakai H, Yano T, Tashiro H, Ohdan H. Morimoto H, et al. Among authors: hashimoto s. Transplant Proc. 2014 Apr;46(3):790-3. doi: 10.1016/j.transproceed.2013.11.092. Transplant Proc. 2014. PMID: 24767350
High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia.
Sato N, Furukawa T, Kuroha T, Hashimoto S, Masuko M, Takahashi H, Yano T, Abe T, Fuse I, Koike T, Kishi K, Aizawa Y. Sato N, et al. Among authors: hashimoto s. Bone Marrow Transplant. 2004 Aug;34(4):299-303. doi: 10.1038/sj.bmt.1704575. Bone Marrow Transplant. 2004. PMID: 15195078
Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.
Takeuchi S, Takamura M, Yoshida T, Takahashi K, Hayashi K, Hashimoto S, Yamagiwa S, Tasaki M, Nakagawa Y, Saito K, Tanabe Y, Tomita Y, Terai S. Takeuchi S, et al. Among authors: hashimoto s. Transplant Proc. 2018 Apr;50(3):884-886. doi: 10.1016/j.transproceed.2018.01.006. Transplant Proc. 2018. PMID: 29661458
GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
Miyata H, Hirohashi Y, Yamada S, Yanagawa J, Murai A, Hashimoto S, Tokita S, Hori K, Abe T, Kubo T, Tsukahara T, Kanaseki T, Shinohara N, Torigoe T. Miyata H, et al. Among authors: hashimoto s. Cancer Immunol Immunother. 2022 Apr;71(4):795-806. doi: 10.1007/s00262-021-03025-z. Epub 2021 Aug 18. Cancer Immunol Immunother. 2022. PMID: 34405274 Free PMC article.
4,617 results